EFSCE
NKTR icon

Enterprise Financial Services Corp (EFSC)’s Nektar Therapeutics NKTR Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3
Closed -$1K – 1333
2020
Q1 		$1K Buy
+3
New +$928 ﹤0.01% 1182
2019
Q3 		– Sell
-133
Closed -$71K – 1168
2019
Q2 		$71K Hold
133
– – 0.02% 351
2019
Q1 		$67K Buy
+133
New +$78.8K 0.01% 359
2018
Q4 		– Sell
-2
Closed -$1K – 1036
2018
Q3 		$1K Buy
+2
New +$1.71K ﹤0.01% 994

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s NKTR Position: Q2 2020 in Review

Enterprise Financial Services Corp (EFSC) sold out of Nektar Therapeutics (NKTR) in Q2 2020, closing a stake of 3 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in NKTR in Q3 2018 and held it in 4 quarters. The position peaked at $71K in Q2 2019. 260 funds tracked by Wall St. Rank hold NKTR as of Q2 2020.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Nektar Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 3 Nektar Therapeutics shares in Q2 2020, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Nektar Therapeutics in Q3 2018 and held it in 4 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Nektar Therapeutics position peaked at $71K in Q2 2019.
  • 260 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2020.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q2 2020, filed 4 Aug 2020.